Add thelocalreport.in As A Trusted Source
Major drugmakers to raise prices on hundreds of drugs drug In the United States, Despite pressure from the Trump administration Price reduction.
The cost of at least 350 brand-name drugs, including vaccine be opposed to Coronavirus diseaseCosts for shingles and cancer treatment Ibrance will increase starting January 1, according to data provided Reuters Developed by healthcare research firm 3 Axis Advisors.
Data shows the number of price increases in 2026 That’s up from the same period last year, when manufacturers revealed plans to raise prices on more than 250 drugs. The median price increase this year is about 4%, similar to 2025.
According to statistics, American patients currently pay the most for prescription drugs, often nearly three times as much as in other developed countries. Reuters, Donald Trump vows he will change that.
Earlier this month, the White House announced it had reached new agreements with nine major pharmaceutical companies to reduce prescription drug use drug prices For Americans: Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSKMerck, Novartis and Sanofi.
The deals are designed to support the government’s Medicaid program for low-income Americans and cash payers, the government said.
However, companies including Pfizer, Sanofi, Boehringer Ingelheim, Novartis and GlaxoSmithKline also plan to increase the prices of some drugs on January 1, according to 3 Axis Advisors.
“These deals are being heralded as transformative, but in fact they’re really just chipping away at the real reasons for high prescription drug prices in the United States,” said Dr. Benjamin Rohm, a health policy researcher at Brigham and Women’s Hospital in Boston. Reuters.
Pfizer announced price increases for about 80 different drugs, including cancer drug Ibrance, migraine drug Nurtec and Paxlovid, which is used to help treat Covid-19, as well as some drugs used in hospitals such as morphine and hydromorphone.
With the exception of the 15% increase in the cost of COVID-19 vaccine Comirnaty, most of Pfizer’s increases have been less than 10%. The company said it had adjusted the average list price for innovative medicines and vaccines in 2026 to be below the rate of general inflation, describing the increase as “modest.”
European drugmaker GlaxoSmithKline (GSK) said it plans to raise prices on about 20 drugs and vaccines from 2% to 8.9%. The company said it is committed to reasonable prices and the price increase is to support scientific innovation.
independent The White House and the drugmakers listed have been contacted Reuters Comment on reported price increases.